Shuta Toru

1.1k total citations
41 papers, 532 citations indexed

About

Shuta Toru is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Shuta Toru has authored 41 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 17 papers in Molecular Biology and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in Shuta Toru's work include Genetic Neurodegenerative Diseases (11 papers), Multiple Sclerosis Research Studies (8 papers) and Mitochondrial Function and Pathology (7 papers). Shuta Toru is often cited by papers focused on Genetic Neurodegenerative Diseases (11 papers), Multiple Sclerosis Research Studies (8 papers) and Mitochondrial Function and Pathology (7 papers). Shuta Toru collaborates with scholars based in Japan, China and South Korea. Shuta Toru's co-authors include Hidehiro Mizusawa, Kinya Ishikawa, Toshiki Uchihara, Tsutomu Tanabe, Hiroto Fujigasaki, Takanori Yokota, Makoto Osanai, Takao Makifuchi, Takayuki Murakoshi and Hiroaki Yokote and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Shuta Toru

38 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuta Toru Japan 12 342 314 181 60 37 41 532
Atsuhiko Sugiyama Japan 12 254 0.7× 203 0.6× 285 1.6× 50 0.8× 24 0.6× 68 573
Priya Shanmugarajah United Kingdom 14 312 0.9× 169 0.5× 254 1.4× 65 1.1× 34 0.9× 23 529
Sarah Camargos Brazil 14 269 0.8× 167 0.5× 452 2.5× 85 1.4× 20 0.5× 51 712
Elisabetta Indelicato Austria 12 221 0.6× 202 0.6× 161 0.9× 31 0.5× 13 0.4× 40 397
Vidosava Rakočević-Stojanović Serbia 19 471 1.4× 354 1.1× 578 3.2× 34 0.6× 22 0.6× 57 831
Robyn Labrum United Kingdom 14 400 1.2× 488 1.6× 175 1.0× 62 1.0× 12 0.3× 21 772
Geneieve Tai Australia 11 390 1.1× 370 1.2× 196 1.1× 28 0.5× 71 1.9× 25 584
Jun‐Hui Yuan Japan 13 314 0.9× 210 0.7× 93 0.5× 133 2.2× 44 1.2× 48 522
Stefania Stenirri Italy 13 157 0.5× 313 1.0× 85 0.5× 61 1.0× 92 2.5× 22 585
Matthew Wicklund United States 12 127 0.4× 223 0.7× 111 0.6× 23 0.4× 23 0.6× 34 412

Countries citing papers authored by Shuta Toru

Since Specialization
Citations

This map shows the geographic impact of Shuta Toru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuta Toru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuta Toru more than expected).

Fields of papers citing papers by Shuta Toru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuta Toru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuta Toru. The network helps show where Shuta Toru may publish in the future.

Co-authorship network of co-authors of Shuta Toru

This figure shows the co-authorship network connecting the top 25 collaborators of Shuta Toru. A scholar is included among the top collaborators of Shuta Toru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuta Toru. Shuta Toru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yokote, Hiroaki, Yusei Miyazaki, Juichi Fujimori, et al.. (2024). Slowly expanding lesions are associated with disease activity and gray matter loss in relapse‐onset multiple sclerosis. Journal of Neuroimaging. 34(6). 758–765. 1 indexed citations
2.
Yokote, Hiroaki, Yusei Miyazaki, Juichi Fujimori, et al.. (2024). Characterization of Japanese multiple sclerosis patients with progression independent of relapse activity: A 2-year multicenter cohort study. Journal of Neuroimmunology. 394. 578407–578407.
3.
Inoue, Kai, Shuta Toru, Yu Hatano, et al.. (2023). Early-onset herpes simplex encephalitis type 1 triggered by COVID-19 disease: A case report. SHILAP Revista de lepidopterología. 19(3). 855–858. 1 indexed citations
4.
Yokote, Hiroaki, Yusei Miyazaki, Shuta Toru, et al.. (2022). High-efficacy therapy reduces subcortical grey matter volume loss in Japanese patients with relapse-onset multiple sclerosis: A 2-year cohort study. Multiple Sclerosis and Related Disorders. 67. 104077–104077. 4 indexed citations
5.
Yu, Xiu‐Jun, Yoshiki Matsuda, Nobuyuki Ozawa, et al.. (2021). Essential roles of plexin-B3+ oligodendrocyte precursor cells in the pathogenesis of Alzheimer’s disease. Communications Biology. 4(1). 870–870. 14 indexed citations
6.
Yokote, Hiroaki, Shuta Toru, Yoichiro Nishida, et al.. (2020). Serum amyloid A level correlates with T2 lesion volume and cortical volume in patients with multiple sclerosis. Journal of Neuroimmunology. 351. 577466–577466. 6 indexed citations
9.
Toru, Shuta, et al.. (2020). Comorbid argyrophilic grain disease in an 87-year-old male with spinocerebellar ataxia type 31 with dementia: a case report. BMC Neurology. 20(1). 136–136. 3 indexed citations
10.
Saito, Kazuyuki, Shuta Toru, Sayuri Shima, & Tatsuro Mutoh. (2018). Anti-neutral glycolipids antibody-positive combined central and peripheral demyelination mimicking encephalomyeloradiculoneuropathy phenotype. Clinical Neurology and Neurosurgery. 172. 90–92. 8 indexed citations
11.
Yamada, Hiroki, Takahiro Takeda, Toshiki Uchihara, et al.. (2018). Macroscopic Localized Subicular Thinning as a Potential Indicator of Amyotrophic Lateral Sclerosis. European Neurology. 79(3-4). 200–205. 3 indexed citations
12.
Yamada, Hiroki, Kazuyuki Saito, Mitsuhiko Hokari, & Shuta Toru. (2017). Brain biopsy to aid diagnosis of neuro-Behçet's disease: Case report and literature review. eNeurologicalSci. 8. 2–4. 3 indexed citations
13.
Toru, Shuta, et al.. (2012). Paradoxical cerebral embolism with patent foramen ovale and deep venous thrombosis caused by a massive myoma uteri. Clinical Neurology and Neurosurgery. 115(6). 760–761. 5 indexed citations
14.
Toru, Shuta, et al.. (2011). Myotonic dystrophy and lipoma: a new association. Neurological Sciences. 33(6). 1477–1478. 1 indexed citations
15.
Toru, Shuta, Toshiki Uchihara, Makoto Takahashi, et al.. (2010). Depletion or Preservation of Cardiac Sympathetic Nerve – An Autopsy-Verified Contrast in Two Cases of Alzheimer’s Disease with or without Lewy Bodies. European Neurology. 64(3). 129–133. 4 indexed citations
16.
Ishikawa, Kinya, M Sakamoto, Taiji Tsunemi, et al.. (2008). Direct and accurate measurement of CAG repeat configuration in the ataxin-1 (ATXN-1) gene by “dual-fluorescence labeled PCR-restriction fragment length analysis”. Journal of Human Genetics. 53(4). 287–295. 4 indexed citations
17.
Amino, Takeshi, Kinya Ishikawa, Shuta Toru, et al.. (2007). Redefining the disease locus of 16q22.1-linked autosomal dominant cerebellar ataxia. Journal of Human Genetics. 52(8). 643–649. 20 indexed citations
18.
Toru, Shuta, et al.. (2005). Somatosensory‐evoked cortical potential during attacks of paroxysmal dysesthesia in multiple sclerosis. European Journal of Neurology. 12(3). 233–234. 3 indexed citations
19.
Li, Ming, Kinya Ishikawa, Shuta Toru, et al.. (2003). Physical map and haplotype analysis of 16q-linked autosomal dominant cerebellar ataxia (ADCA) type III in Japan. Journal of Human Genetics. 48(3). 111–118. 21 indexed citations
20.
Toru, Shuta, Takayuki Murakoshi, Kinya Ishikawa, et al.. (2000). Spinocerebellar Ataxia Type 6 Mutation Alters P-type Calcium Channel Function. Journal of Biological Chemistry. 275(15). 10893–10898. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026